Hydromorphone for acute and chronic pain

  • Withdrawn
  • Review
  • Intervention


Anna Hobson, Cochrane Pain, Palliative & Supportive Care Group, Pain Research Unit, The Churchill Hospital, Old Road, Oxford, OX3 7LE, UK. anna.hobson@ndcn.ox.ac.uk.

Reason for withdrawal from publication

The original author team were unavailable to complete the update. At September 2013, a new author team is preparing a new protocol for publication in early 2014, with the revised title 'Hydromorphone for cancer pain'.

The editorial group responsible for this previously published document have withdrawn it from publication.

What's new

25 October 2013AmendedThis review has now been withdrawn following the new protocol in preparation. See Published notes.


Protocol first published: Issue 1, 2002
Review first published: Issue 1, 2002

16 September 2013AmendedThis review is being updated following a new protocol in preparation and will be withdrawn when the new review is published. See Published notes.
1 September 2008AmendedConverted to new review format.
16 August 2007New search has been performedThis update identified five new trials (Chang 2006; Grosset 2005; Kopp 2000; Lehmann 2001; Wolanskyj 2000), which brings the total of included studies up to 48. The new trials located in this updated search have provided no additional information nor changed the original reviews results and conclusions.